Literature DB >> 32951336

Review: How has cognitive behaviour therapy been adapted for adolescents with comorbid depression and chronic illness? A scoping review.

Alice Morey1, Maria E Loades1,2.   

Abstract

BACKGROUND: Depression becomes increasingly common in adolescence. Around 10%-20% of adolescents have a chronic illness, and they are more likely to experience depression. There is emerging evidence for cognitive behaviour therapy (CBT) interventions to treat depression in adolescents with chronic illnesses, yet no review has been undertaken of how these CBT interventions are delivered in practice.
METHODS: We conducted a scoping review to summarise how CBT has been delivered in adolescents with chronic illness and depression. We included studies that evaluated CBT aimed at treating depression/depressive symptoms in adolescents with chronic illness. Searches were carried out across Embase and PsycNET.
RESULTS: Twelve studies met our inclusion criteria. These included diabetes (n = 3), inflammatory bowel disease (n = 3), polycystic ovary syndrome (n = 2), chronic headache (n = 1), chronic pain (n = 1), chronic fatigue syndrome (n = 1) and Fanconi anaemia (n = 1). Adaptations made to the delivery of CBT included cognitive restructuring of illness-related thoughts, behavioural activation balancing illness-related and enjoyable activities, psychoeducation of the comorbidity and link between the chronic illness and depression, relationship building, skill building and parental or familial involvement. CBT was typically delivered by trained professionals with expertise in working with adolescents, who worked under supervision.
CONCLUSIONS: CBT for depression is commonly adapted for this population, and the nature of cognitions and behaviours targeted in CBT may typically depend on how the chronic illness presents. There is relatively little evidence to date, and a need for more research into the efficacy and effectiveness of treatments for adolescent depression in this vulnerable population specifically.
© 2020 The Authors. Child and Adolescent Mental Health published by John Wiley & Sons Ltd on behalf of Association for Child and Adolescent Mental Health.

Entities:  

Keywords:  CBT; chronic illness; depression; mood; paediatric

Year:  2020        PMID: 32951336     DOI: 10.1111/camh.12421

Source DB:  PubMed          Journal:  Child Adolesc Ment Health        ISSN: 1475-357X            Impact factor:   2.175


  4 in total

Review 1.  Models of lifelong care for children and adolescents with chronic conditions in low-income and middle-income countries: a scoping review.

Authors:  Lindsey K Reif; Josefien van Olmen; Margaret L McNairy; Saeed Ahmed; Nande Putta; Raoul Bermejo; Rachel Nugent; Elijah Paintsil; Bernadette Daelmans; Cherian Varghese; Nandita Sugandhi; Elaine J Abrams
Journal:  BMJ Glob Health       Date:  2022-07

2.  Efficacy of Motivational Interviewing to Improve Utilization of Mental Health Services Among Youths With Chronic Medical Conditions: A Cluster Randomized Clinical Trial.

Authors:  Christina Reinauer; Anna Lena Platzbecker; Rabea Viermann; Matthias Domhardt; Harald Baumeister; Katharina Foertsch; Hannah Linderskamp; Lisa Krassuski; Doris Staab; Kirsten Minden; Reinhold Kilian; Reinhard W Holl; Petra Warschburger; Thomas Meißner
Journal:  JAMA Netw Open       Date:  2021-10-01

3.  Feasibility and potential efficacy of a guided internet- and mobile-based CBT for adolescents and young adults with chronic medical conditions and comorbid depression or anxiety symptoms (youthCOACHCD): a randomized controlled pilot trial.

Authors:  A Geirhos; M Domhardt; F Lunkenheimer; S Temming; R W Holl; K Minden; P Warschburger; T Meissner; A S Mueller-Stierlin; H Baumeister
Journal:  BMC Pediatr       Date:  2022-01-29       Impact factor: 2.125

Review 4.  Psychological and Psychiatric Comorbidities in Youth with Serious Physical Illness.

Authors:  Sohail Nibras; Rachel Kentor; Yasir Masood; Karin Price; Nicole M Schneider; Rachel B Tenenbaum; Chadi Calarge
Journal:  Children (Basel)       Date:  2022-07-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.